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http://dxObjectives: Remote ischemic preconditioning (rIPC) reduces myocardial injury in adults and children under-
going cardiac surgery. We compared the effect of rIPC in adult and neonatal rabbits to investigate whether pro-
tection against ischemia-reperfusion injury can be achieved in the newborn heart by (1) in vivo rIPC and (2)
dialysate from adult rabbits undergoing rIPC.
Methods: Isolated hearts from newborn and adult rabbits were randomized into 3 subgroups (control, in vivo
rIPC, and dialysate obtained from adult, remotely preconditioned rabbits). Remote preconditioning was induced
by four 5-minute cycles of lower limb ischemia. Left ventricular (LV) function was assessed using a balloon-
tipped catheter, glycolytic flux by tracer kinetics, and infarct size by tetrazolium staining. Isolated hearts
underwent stabilization while perfused with standard Krebs-Henseleit buffer (control and in vivo rIPC) or
Krebs-Henseleit buffer with added dialysate, followed by global no-flow ischemia and reperfusion.
Results:Within the age groups, the baseline LV function was similar in all subgroups. In the adult rabbit hearts,
rIPC and rIPC dialysate attenuated glycolytic flux and protected against ischemia-reperfusion injury, with
better-preserved LV function comparedwith that of the controls. In contrast, in the neonatal hearts, the glycolytic
flux was lower and LV function was better preserved in the controls than in the rIPC and dialysate groups. In the
adult hearts, the infarct size was reduced in the rIPC and dialysate groups compared with that in the controls. In
the neonatal hearts, the infarct size was smaller in the controls than in the rIPC and dialysate groups.
Conclusions: Remote ischemic preconditioning does not protect against ischemia-reperfusion injury in isolated
newborn rabbit hearts and might even cause deleterious effects. Similar adverse effects were induced by dialy-
sate from remotely preconditioned adult rabbits. (J Thorac Cardiovasc Surg 2014;147:1049-55)Impaired ventricular systolic and diastolic function is an
important contributor to the mortality and morbidity
associated with pediatric cardiac surgery,1,2 particularly
after complex surgery performed in the neonate and
young infant. The immature heart is structurally,
functionally, and metabolically different from the adult
heart and undergoes fundamental changes around the time
of birth; however, our understanding of the detailed
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SIdentification of the physiologic differences in the
developing myocardium is a prerequisite to understanding
the underlying mechanisms of myocardial protection and
devising new strategies for protecting the immature heart
during cardiac surgery.
Remote ischemic preconditioning (rIPC), induced by cy-
cles of ischemia and reperfusion of a limb before surgery,
has recently emerged as a potential method of averting
myocardial injury during cardiopulmonary bypass in older
children3 and adults4 undergoing cardiac surgery; however,
no studies are available of its effectiveness in the immature
heart. This is important, because evidence from experimen-
tal studies of local ischemic preconditioning, in which the
cycles of ischemia and reperfusion were applied directly
to the tissue subjected to prolonged ischemia, has shown
that the responses might display distinct maturational de-
pendence. For example, some studies have shown that the
ability to achieve cardioprotection from local ischemic pre-
conditioning is not present in fetal life and only becomes
apparent after 1 to 4 weeks (depending on the species)
after birth.5-7 However, others have shown effective
pharmacologic and ischemic preconditioning in immature
rabbit hearts8 and isolated neonatal cardiomyocytes.9,10diovascular Surgery c Volume 147, Number 3 1049
Abbreviations and Acronyms
IR ¼ ischemia-reperfusion
dP/dtmax ¼ maximal dP/dt
dP/dtmin ¼ minimal dP/dt
KH ¼ Krebs-Henseleit
LV ¼ left ventricular
LVDP ¼ LV developed pressure
rIPC ¼ remote ischemic preconditioning
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mechanisms underlying ‘‘preconditioning resistance’’
remain unknown, although the immature myocardium
consistently appears intrinsically more resistant to hypoxia
and possibly ischemia,6,11 raising the possibility that it is
already ‘‘preconditioned’’ in some way.
Moreover, the transition from immature, predominantly
carbohydrate-dependent myocardial metabolism to the ma-
ture ‘‘omnivore’’ myocardium occurs—with some species
variation—within the first weeks of life.12 Also, although
local ischemic preconditioning attenuates glycolytic flux
in the mature myocardium,13 it is unknown whether this ef-
fect is present and beneficial in the carbohydrate-dependent
immature myocardium.
Nonetheless, the relevance of these studies to rIPC is
questionable, because rIPC does not involve ischemic
bursts of the myocardium itself to induce the precondi-
tioned state. However, in an excellent recent study by Jones
et al,14 no detectable cardioprotection was achieved by rIPC
in hypoxic neonates undergoing cardiopulmonary bypass
surgery.
We have recently shown that rIPC liberates a small (<15
kDa), hydrophobic cardioprotective factor into the blood-
stream, which is dialyzable from plasma and transferable
from rabbit to rabbit to protect against ischemia-
reperfusion (IR) injury in Langendorff preparations.15
The purpose of the present study was to use the unique
properties of rIPC to study the following questions:
1. Does rIPC protect the isolated newborn rabbit heart from
IR injury?
2. Does dialysate from adult rabbits undergoing rIPC pro-
tect the isolated newborn rabbit heart from IR injury?METHODS
Design
IR injury was studied in isolated hearts from 24 newborn (1-2 days old,
randomized to 3 groups of 8 animals) and 24 adult rabbits (3 months old,
randomized to 3 groups of 8 animals). An additional 16 adult rabbits
were used as donors of blood after undergoing rIPC. Blood from 1 adult
rabbit provided enough dialysate for 1 isolated newborn or adult. Conse-
quently, 6 groups were studied:
1. Adult hearts subjected to IR injury alone (see below for details)
2. Adult hearts subjected to IR injury after in vivo rIPC1050 The Journal of Thoracic and Cardiovascular Sur3. Adult hearts subjected to IR injury after perfusion with dialysate from
a donor rabbit undergoing rIPC
4. Newborn hearts subjected to IR injury alone (see below for details)
5. Newborn hearts subjected to IR injury after in vivo rIPC
6. Newborn hearts subjected to IR injury after perfusion with dialysate
from an adult donor rabbit undergoing rIPCRabbits
The rabbits were handled according to the guidelines appointed by the
Danish Committee for Animal Research (Dyreforsøgstilsynet, Copenha-
gen, Denmark). Adult (3-kg), male, white, New Zealand rabbits were
housed in single cages and provided with access to food and water ad
libitum. Newborn (aged 2-4 days; weight, 150-200 g), white New Zealand
rabbits were kept with their mother until the time of study.
Anesthesia and Ventilation
In brief, all the rabbits (neonatal and adult) were anesthetized with a sub-
cutaneous injection of a mixture of midazolam (Dormicum) and etomidate
(Hypnorm). When an adequate depth of anesthesia had been confirmed,
a tracheotomy was performed, and the rabbit was mechanically ventilated
(Ugo Basile, Comerio, Italy).
rIPC Protocol
The rabbits used as blood donors and the rabbits in the in vivo rIPC
groups underwent the same preconditioning protocol. After sedation and
intubation, rIPC was performed using tourniquet occlusion of the lower
left limb for 4 cycles of 5 minutes of ischemia followed by 5 minutes of
reperfusion (40 minutes total). The rabbit remained sedated and ventilated
for an additional 20 minutes before the heart was explanted or blood was
taken for dialysis.
Blood Sampling and Dialysis Preparation
The rabbits used as blood donors had a 5F sheath inserted into the
right common carotid artery. Blood was rapidly withdrawn through the
sheath for a period of 2 minutes to avoid hemodynamic disturbance.
The adult rabbits yielded approximately 150 mL of whole blood that
was collected in heparinized tubes and spun at 3000 rpm for 20 minutes
at 4C. The plasma was separated and dialyzed against sterile water
through a 15-kDa Spectrapor dialysis membrane (Spectrum Laboratories,
Rancho Dominguez, Calif) for 12 hours at 4C. The dialysate was subse-
quently diluted to provide a 10% concentration in a standard Krebs-
Henseleit (KH) buffer (see below). The dialysate was divided into equal
portions, supplying the substrate needed for 1 neonatal and 1 adult iso-
lated heart.
Nonworking Langendorff IR Injury Protocol
A laparotomy and thoracotomy were performed, and the heart was dis-
sected free from the surrounding structures. A bolus of 1000 IU/kg hep-
arin (Leo Pharma, Copenhagen, Denmark) was given through the femoral
vein. The heart was cannulated in situ, mounted on the Langendorff ap-
paratus, and perfused retrogradely with KH buffer (NaCl 118.5 mmol/L,
KCl 4.7 mmol/L, NaHCO3 25.0 mmol/L, glucose monohydrate 11.1
mmol/L, MgSO4,7H2O 1.2 mmol/L, CaCl2 2.4 mmol/L, and KH2PO4
1.2 mmol/L; Sigma Aldrich, St Louis, Mo) at a pressure of 70 mm Hg.
The perfusion solution was fully oxygenated with 95% oxygen and
5% carbon dioxide and maintained at 37C. The hearts were allowed
to stabilize for 20 minutes. For the next 35 minutes, the hearts in groups
3 and 6 were switched to KH buffer with 10% adult dialysate, and the
hearts in the other groups were perfused only with standard KH buffer.
All hearts were then subjected to 40 minutes of normothermic global
no-flow ischemia and subsequently 120 minutes of reperfusion with stan-
dard KH solution.gery c March 2014
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Left ventricular (LV) function was measured with a balloon catheter
placed in the left ventricle through the mitral valve and connected to a pres-
sure transducer. The data were sampled using a high-fidelity analog to dig-
ital hardware to dedicated data acquisition software (Notocord, Croissy Sur
Seine, France). The derived indexes of systolic (maximal dP/dt [dP/dtmax])
and diastolic (minimal dP/dt [dP/dtmin]) function were calculated automat-
ically by the software program.
Assessment of Myocardial Infarction
At the end of the experiment, the hearts were frozen at 80C for 15
minutes, subsequently cut into 1.5-mm slices, and immersed in 1%
2,3,5-triphenyltetrazolium chloride (Sigma Aldrich) at 37C for 3 minutes
at pH 7.4. The hearts were then stored overnight in 2 mL of Lillie’s solution
(4% formaldehyde buffer; VWR International, Herlev, Denmark) to en-
hance the color contrast. The next day, each heart was weighed and scanned
with a flatbed scanner (HP ScanJet 4300C; Hewlett Packard, Palo Alto, Ca-
lif). The area of the left ventricle and the area of infarction were assessedTABLE 1. Hemodynamic parameters
Variable
Before ischemia
Baseline 40 min
P value
(vs contr
LVDP (mm Hg)
Neonatal control 48.8  3.2 41.2  3.6
Neonatal rIPC 37.5  8.5 36.4  8.0 <.05
Neonatal rIPC dialysate 43.9  3.4 31.5  3.6 <.01
Adult control 115.5  7.8 113.6  6.8
Adult rIPC 109.7  6.0 110.1  6.5 NS
Adult rIPC dialysate 115.3  18.1 116.1  11.0 NS
HR (beats/min)
Neonatal control 195.5  11.3 218.1  13.7
Neonatal rIPC 228.1  11.5 228.1  23.1 NS
Neonatal rIPC dialysate 214.1  20.2 212.8  21.8 NS
Adult control 187.3  8.0 172.6  7.9
Adult rIPC 174.2  5.8 157.9  9.6 <.05
Adult rIPC dialysate 214.0  15.4 186.1  18.6 <.05
dP/dtmin (mm Hg/s)
Neonatal control 1310.3  241.9 1044.3  153.4
Neonatal rIPC 775.8  185.3 812.8  166.7 <.01
Neonatal rIPC dialysate 855.5  127.9 634.7  175.3 <.001
Adult control 1576.0  105.8 1580.2  105.2
Adult rIPC 1464.0  69.8 1537.1  149.3 NS
Adult rIPC dialysate 1645.4  176.4 1758.5  158.7 NS
dP/dtmax (mm Hg/s)
Neonatal control 930.3  193.1 884.9  234.0
Neonatal rIPC 914.5  261.7 744.3  195.7 NS
Neonatal rIPC dialysate 774.0  397.9 533.7  290.6 NS
Adult control 1994.4  282.0 2128.3  185.5
Adult rIPC 1748.9  162.1 1825.6  192.0 NS
Adult rIPC dialysate 2186.6  288.4 2139.5  318.8 NS
Coronary flow (mL/min)
Neonatal control 11.7  3.2 9.6  1.6
Neonatal rIPC 11.1  0.6 11.7  0.9 NS
Neonatal rIPC dialysate 8.7  1.5 8.2  1.7 NS
Adult control 56.0  3.8 53.0  4.3
Adult rIPC 57.7  6.1 54.9  6.0 NS
Adult rIPC dialysate 70.6  7.6 61.7  3.8 NS
LVDP, Left ventricular developed pressure; rIPC, remote ischemic preconditioning; NS, n
The Journal of Thoracic and Carsemiautomatically by computer planimetry (UTHSCSA Image Tool for
Windows, version 3.0, San Antonio, Tex). The infarct size was calculated
by summing the percentage of infarction from each slice, expressed as
a function of slice weight. All analyses were performed by a blinded
observer.
Tracer Kinetics
Glycolytic flux from exogenous glucose was measured using statically
labeled tritiated D-[5-3H] glucose (PerkinElmer, Waltham, Mass) added to
KH buffer at a mixture of 10 mCi/200 mL perfusate. The specific activity of
glucose (5 mCi/mmol) was determined by counting the emission from an
aliquot of perfusate collected at the beginning of each experiment. The flux
of exogenous glucose to pyruvate was assessed by the measurement of tri-
tiated 3H2O production at the site of enolase.
16
Aliquots of coronary effluent were sampled every 5 minutes, and the
metabolic rate calculations were corrected for ‘‘arterial’’ aliquots sampled
from the bottom of the oxygenator. The separation of tritiated glucose from
3H2O was performed using anion exchange chromatography on an AGReperfusion
ol) 10 min 30 min 120 min
P value
(vs control)
21.1  2.5 31.0  2.3 24.0  2.2
11.3  2.3 14.9  2.5 11.0  2.0 <.01
9.6  2.5 13.3  2.3 8.0  2.2 <.01
4.9  1.4 9.1  2.2 8.8  2.3
17.2  6.4 21.1  3.5 25.4  4.6 <.01
20.6  5.7 23.3  4.7 30.8  5.6 <.01
195.5  11.3 228.1  11.5 200.2  14.3
205.1  20.8 225.4  19.5 223.4  19.0 NS
212.8  5.0 219.9  21.3 203.8  19.4 NS
196.1  30.7 212.5  35.2 181.5  20.4
180.2  31.6 151.6  11.2 147.4  6.3 <.05
174.1  11.9 157.3  27.0 185.6  5.2 NS
507.1  167.5 683.9  109.2 567.3  127.8
261.4  30.0 329.4  34.6 288.8  36.1 <.01
202.6  23.6 270.3  66.0 205.4  70.0 <.01
266.9  53.6 368.3  81.6 398.9  70.5
610.1  171.9 518.8  94.1 616.0  124.3 <.01
662.7  126.8 368.3  81.6 398.9  70.5 <.01
420.7  193.2 567.8  267.5 475.8  251.9
311.7  50.4 324.7  34.6 257.5  28.8 <.05
252.3  107.5 312.9  102.6 230.4  145.5 <.05
261.5  51.3 369.5  89.6 408.1  77.2
567.1  127.8 541.1  94.3 617.2  99.1 <.01
640.4  115.3 647.7  141.0 775.2  142.8 <.01
12.8  2.0 12.8  1.5 9.6  1.3
13.7  1.0 13.0  0.9 12.4  1.9 NS
11.3  2.9 10.3  1.3 14.1  1.2 NS
35.1  6.0 42.2  5.8 33.5  5.7
45.6  6.9 41.5  5.3 31.5  6.6 <.07
50.5  5.3 46.2  5.5 40.6  8.4 <.05
ot significant; HR, heart rate; dP/dtmax, maximal dP/dt; dP/dtmin, minimal dP/dt.
diovascular Surgery c Volume 147, Number 3 1051
E
T
/B
S
Adult LVDP
0 50 100 150 200 250
0
20
40
60
80
100
120
140
Control
rIPC
rIPC Dialysate
Isc
he
m
ia
P<0.01
P<0.01
Time (minutes)
m
m
H
g
Neonatal LVDP
0 50 100 150 200 250
0
20
40
60
80
Control
rIPC
rIPC Dialysate
Is
ch
e
m
ia
P<0.01
P<0.01
Time (minutes)
m
m
H
g
FIGURE 1. Left ventricular systolic function in neonatal and adult rabbit hearts. LVDP, Left ventricular developed pressure; rIPC, remote ischemic pre-
conditioning.
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S1-X8 resin column (Bio-Rad Laboratories, Hercules, Calif). The 3H2O
was dissolved in 10 mL OptiPhase scintillation solution (Perkin-Elmer,
Waltham,Mass), and the amount was quantified by b-scintillation counting
on a TriCarb 2900TR liquid scintillation analyzer (Perkin-Elmer). The
glycolytic flux during both stabilization and reperfusion was calculated
by dividing the counts per minute by the specific activity of the glucose
in the perfusate. The results were plotted against time, and the glycolytic
flux rate was calculated.
Statistical Analysis
All values are presented as the mean  standard error of the mean. The
LV developed pressure (LVDP) was calculated as the difference between
the LV systolic pressure and LV diastolic pressure. Hemodynamic data
were compared using 2-way analysis of variance, with repeated measures.
One-way analysis of variance was used to compare the infarct size and he-
modynamic parameters at dedicated measurement points (Table 1). The
glycolytic flux data were assessed using 1-way analysis of variance of
the area under the curve. P ¼ .05 was considered statistically significant.
Statistical analyses were performed using GraphPad Prism, version 5.01
(GraphPad Software, San Diego Calif).RESULTS
A total of 39 newborn and 45 adult rabbits were used in
this project, because 15 neonatal and 5 adult rabbits died
of technical or surgical problems before inclusion in the
study.Baseline Characteristics
The hearts from the newborn rabbits did not differ among
the groups at baseline with regard to the LVDP, heart rate,
rate pressure-product, dP/dtmin, dP/dtmax, and LV end-FIGURE 2. Glycolytic flux. rIPC, R
1052 The Journal of Thoracic and Cardiovascular Surdiastolic pressure. Similarly, the , heart rate, dP/dtmin, dP/
dtmax, and LV end-diastolic pressure were equal at baseline
in the hearts from the adult rabbits (Table 1). No differences
in coronary perfusion between both neonatal and adult
groups were observed throughout the study (Table 1).LV Function After rIPC
In neonatal hearts, the LVDP (Figure 1), rate pressure-
product, and dP/dtmax were significantly higher during re-
perfusion in the controls than in the neonatal hearts treated
with either in vivo rIPC or dialysate from remotely precon-
ditioned adult rabbits, suggesting that rIPC impairs post-IR
functional recovery (Table 1).
In the hearts from adult rabbits, the systolic and diastolic
performance was similar before global ischemia; however,
the hearts treated with either in vivo rIPC or dialysate
from remotely preconditioned adult rabbits had signifi-
cantly greater LVDPs, rate pressure-products, and dP/dtmax
and lower dP/dtmin, thus, showing the expected protection
against systolic and diastolic dysfunction during reperfu-
sion (Table 1 and Figure 1).
Neonatal hearts exposed to either in vivo rIPC or rIPC di-
alysate had a significantly lower LVDP (P<.05 and P<.01)
than did the controls even before ischemia. Similarly, the
dP/dtmin was significantly higher in the treated neonatal
groups than in the controls. In contrast, no differences
were found in the LVDP, dP/dtmax, and dP/dtmin among
the adult groups before ischemia.emote ischemic preconditioning.
gery c March 2014
FIGURE 3. Glycolytic flux in early reperfusion. rIPC, Remote ischemic preconditioning.
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Glycolytic flux was significantly greater in all neonatal
groups than in the adult groups throughout the protocol
(Figure 2). In neonatal hearts, no difference was found be-
tween groups before ischemia. However, in early reperfu-
sion (the first 5 minutes), the neonatal hearts treated with
in vivo rIPC had significantly higher glycolytic flux
(P< .01), with a trend toward higher flux in the hearts
treated with adult rIPC dialysate (P<.07; Figure 3).
In contrast, adult hearts treated with either in vivo rIPC or
dialysate from remotely preconditioned adult rabbits
showed significantly lower glycolytic flux during early re-
perfusion (P<.01 and P<.05, respectively; Figure 3).Infarct Size
The infarct size tended to be larger in the neonatal hearts
treated with either in vivo rIPC (P ¼ .06) and was signifi-
cantly larger in the neonatal hearts treated with dialysate
from remotely preconditioned adult rabbits (P<.01) com-
pared with the neonatal control hearts. In contrast, adult
hearts treated with either in vivo rIPC or dialysate fromNeonatal
Infarct size of left ventricle
Control rIPC rIPC dialysate
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FIGURE 4. Infarct size. rIPC, Remote ische
The Journal of Thoracic and Carremotely preconditioned adult rabbits had a significantly
smaller infarct size than the controls (both P < .01;
Figure 4).
The neonatal control hearts recovered significantly better
after prolonged ischemia, with the LVDP after 2 hours of re-
perfusion reaching 49.9%  22% of baseline compared
with adult control hearts, which regained only 8.1% 
6.7% of baseline LVDP after 2 hours of reperfusion
(P< .01). The neonatal control hearts had a significantly
smaller infarct size, with an infarct size/area at risk of
60.6%  10.5%, compared with an infarct size/area at
risk of 81.8%  7.8% in the adult control hearts (P<.01).DISCUSSION
The results of the present study have confirmed the lack
of neonatal cardioprotection by rIPC observed in the clini-
cal trial by Jones et al14 and, to our knowledge, is the first
study to investigate the acute functional and metabolic ef-
fects of rIPC on the neonatal heart. Previous studies have
shown that immature hearts from various species are neither
harmed nor consistently protected by local ischemicAdult
Infarct size of left ventricle
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mic preconditioning; LV, left ventricular.
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expected deleterious effects of rIPC in the neonatal rabbit
heart. Although the results in the adult hearts were consis-
tent with our previous findings,15 the infarct size was larger
and functional recovery was poorer in the neonatal hearts
subjected to either rIPC in vivo or when treated with dialy-
sate from remotely preconditioned adult rabbits. This detri-
mental effect was associated with increased glycolytic flux
during the early reperfusion period in the neonatal myocar-
dium, although the opposite will be seen in association with
cardioprotection in the adult heart. However, no certain cau-
sality between the changes in glycolytic flux and cardiopro-
tection has been established.
In addition to the divergent responses to rIPC, neonatal
and adult hearts displayed important differences in the re-
sponses to IR injury alone. Newborn and adult hearts in
all groups showed impaired systolic function after pro-
longed ischemia; however, the neonatal control hearts re-
gained approximately 50% of baseline LVDP during
reperfusion. In contrast, the adult control hearts regained
less than 10% of the baseline LVDP during reperfusion.
The negative effect of rIPC and dialysate on neonatal LV
function appeared even before the IR injury, indicating
that this detrimental effect—although apparently empha-
sized by IR injury—also affects the unstressed neonatal
heart. Furthermore, the infarct size in adult control hearts
was significantly larger than that observed in the neonatal
control hearts, suggesting that the neonatal heart has an in-
herent pre-existing level of protection that is clearly ad-
versely modified by additional rIPC.
The present study was not designed to examine the mech-
anisms of the adverse effects of rIPC. However, some in-
sights into the possible modification of responses can be
seen from our data on glycolytic flux. The neonatal hearts,
being highly dependent on a carbohydrate metabolism, had
an expected higher glycolytic flux throughout the protocol
than the adult hearts. However, although adult hearts ex-
posed to rIPC exhibited reduced glycolytic flux in early re-
perfusion, the neonatal hearts treated with in vivo rIPC had
increased glycolytic flux compared with the controls. Al-
though speculative, it appears that rIPC in the neonatal heart
increases the need for adenosine triphosphate production
through glycolysis during early reperfusion but that a reduc-
tion in the glycolytic rate appears to be associated with the
protective effect in the adult heart.
Irrespective of the mechanisms, our data are important
because they raise questions about the advisability of
rIPC as an additional cardioprotective strategy in the early
neonatal period for children undergoing cardiac surgery.
Because of its simplicity and apparent lack of adverse ef-
fects, rIPC has rapidly translated to clinical trials of older
patients. However, we would strongly advise that additional
mechanistic studies of the detailed metabolism in the neo-
natal heart be performed before widespread clinical use is1054 The Journal of Thoracic and Cardiovascular Surinitiated. Furthermore, because congestive heart failure
and hypertrophic cardiomyopathy seem to induce a rever-
sion of the myocardial metabolism toward a more immature
pattern,17,18 these finding could have implications regarding
the utility of rIPC in other patient groups.
Study Limitations
Isolated heart preparations provide the possibility of
studying the effects of interventions and avoiding extrinsic
factors that could influence the outcome. In the present
study, the model allowed us to compare the direct effect
on neonatal and adult rabbit hearts of dialysate from re-
motely preconditioned adult rabbits with that of hearts
from in vivo preconditioned and control rabbits. However,
this ability to study an isolated effect on the heart is gained
at the expense of eliminating the physiologic context, and
the model might not completely reflect how the bioactive
substances from the dialysate would affect the heart
in vivo. Furthermore, the dialysate was diluted to 10% of
the in vivo concentration and the dialyzation itself—al-
though preserving the substances protecting the adult
hearts—could have eliminated the cardioprotective sub-
stances acting on the neonatal heart. Nevertheless, the
dual-string design assessing both remote ischemic condi-
tioning dialysate and in vivo rIPC and showing similar ef-
fects for the 2 interventions supports the hypothesis that
the difficulties in achieving neonatal cardioprotection are
related to the heart itself, rather than the signaling mecha-
nisms of rIPC. However, most neonatal IR injury models,
including the present one, have been more or less directly
copied from adult models, and the window of potential car-
dioprotection might be different in the neonatal heart (eg,
shorter or longer ischemia periods, delayed response).
Finally, the increased infarct size observed in the in vivo
remotely preconditioned neonatal hearts was only border-
line significant. Although an infarct-increasing effect of
rIPC in the neonatal hearts was supported by the signifi-
cantly larger infarcts in the dialysate group, the increase ap-
peared to be small and most likely of limited clinical
significance.
Clinical Perspectives
Our data have several important implications for future
studies of rIPC in neonates and young infants. Our observa-
tions of impaired myocardial performance and increased in-
fract size mandate that any clinical study should include
a careful evaluation of the effects of the rIPC stimulus itself,
before inclusion as a potential therapy in clinical trials.
CONCLUSIONS
The neonatal heart is inherently more resistant to IR in-
jury than the adult heart. However, this intrinsic protection
was reversed when rIPC was performed in vivo, and similar
detrimental effects were observed if isolated newborn rabbitgery c March 2014
Schmidt et al Evolving Technology/Basic Sciencehearts were perfused with dialysate from remotely precon-
ditioned adult rabbits. More studies are clearly required to
better understand the mechanisms of these findings and
the ontogeny of early adaptation, before the translation of
rIPC to clinical studies.
However, untreated isolated newborn rabbit hearts devel-
oped smaller infarcts after IR than did the untreated adult
hearts, indicating that the neonatal heart is inherently
more resistant to IR injury.References
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